ArticleBMC microbiology2026
Emergence of hypervirulent Klebsiella pneumoniae ST111 with a novel virulence plasmid causing pyogenic liver abscess.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveHypervirulent Klebsiella pneumoniae (hvKp)-associated pyogenic liver abscess is most commonly linked to K1/K2 capsule serotypes and canonical lineages such as ST23, ST65, and ST86. Reports of hvKp outside these lineages remain rare but carry significant public health implications. We investigated an unusual case of liver abscess in an immunocompetent patient caused by hvKp sequence type 111 (ST111).
methodsFive isolates (KP1-KP5) recovered from a patient with pyogenic liver abscess were characterized by antimicrobial susceptibility testing, whole-genome sequencing, and pulsed-field gel electrophoresis. To investigate the contribution of the virulence plasmid to the host strain, CRISPR/Cas9-mediated plasmid curing was performed, followed by functional analyses including phenotypic characterization and a murine infection model. In addition, comparative genomic analyses were conducted to elucidate the epidemiological relationships and genetic determinants underlying hypervirulence.
resultsThe five isolates recovered from the patient were genetically identical. Genomic analysis identified a 181 kb IncHI1B/IncFIB virulence plasmid encoding rmpADC and the salmochelin cluster (iroBCDN), but lacking iuc and rmpA2. Remarkably, the plasmid also carried the yersiniabactin locus (ybt), typically chromosomal in origin. Comparative genomics revealed that similar ST111 strains have been reported exclusively in China, suggesting clonal expansion of a previously unrecognized hvKp lineage. Functional assays demonstrated that plasmid curing abolished the hypermucoviscous phenotype, reduced capsule production, and completely attenuated virulence in murine models, confirming the plasmid as the principal driver of hypervirulence. Interestingly, plasmid loss enhanced biofilm formation and alleviated growth burden, indicating fitness trade-offs associated with virulence.
conclusionThis study describes a rare case of hvKp ST111 liver abscess and identifies a novel plasmid conferring hypervirulence. These findings broaden the recognized diversity of hvKp and highlight that non-canonical lineages can acquire potent virulence determinants capable of causing severe disease. Ongoing clinical and genomic surveillance is essential to detect and contain emerging hvKp clones before widespread dissemination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.